Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome

Clinical Microbiology and Infection

Volumn 19, Issue 2, 2013, Pages

  Heikema, A P ^a   Jacobs, B C ^a   Horst Kreft, D ^a   Huizinga, R ^a   Kuijf, M L ^a   Endtz, H P ^a   Samsom, J N ^a   van Wamel, W J B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Campylobacter jejuni; Disialylation; Lipo oligosaccharide; Miller Fisher Syndrome; Siglec 7

Indexed keywords

GANGLIOSIDE GQ 1B ANTIBODY; LIPOOLIGOSACCHARIDE; SIALIC ACID; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN 7; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; ARTICLE; CAMPYLOBACTER JEJUNI; GUILLAIN BARRE SYNDROME; HUMAN; MEDICAL RECORD; NONHUMAN; OCULOMOTOR WEAKNESS; PRIORITY JOURNAL; PROTEIN BINDING; SEROLOGY; WEAKNESS;

CAMPYLOBACTER JEJUNI;

EID: 84873521811     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12073     Document Type: Article

References (38)

1. Hahn AF. Guillain-Barré syndrome. Lancet 1998; 352: 635-641.
2. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet 2005; 366: 1653-1666.
3. Tam CC, O'Brien SJ, Petersen I, Islam A, Hayward A, Rodrigues LC. Guillain-Barré syndrome and preceding infection with Campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS ONE 2007; 2: e344.
4. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 2008; 7: 939-950.
5. Fisher M. An unusual variant of acute idiopathic polyneuritis: syndrome of ophthalmoplegia, ataxia and areflexia. N Engl J Med 1956; 255: 57-65.
6. Funakoshi K, Kuwabara S, Odaka M, Hirata K, Yuki N. Clinical predictors of mechanical ventilation in Fisher/Guillain-Barré overlap syndrome. J Neurol Neurosurg Psychiatry 2009; 80: 60-64.
7. Rajabally YA, Hassan-Smith G, Notturno F et al. Motor and sensory conduction failure in overlap of Guillain-Barré and Miller Fisher syndrome: two simultaneous cases. J Neurol Sci 2011; 303: 35-38.
8. Jacobs BC, Rothbarth PH, van der Meché FGA et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 1998; 51: 1110-1115.
9. Koga M, Gilbert M, Li J et al. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 2005; 64: 1605-1611.
10. Godschalk PC, Kuijf ML, Li J et al. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barré and Miller Fisher syndromes. Infect Immun 2007; 75: 1245-1254.
11. Hafer-Macko CE, Sheikh KA, Li CY et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 1996; 39: 625-635.
12. Yuki N, Susuki K, Koga M et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc Natl Acad Sci USA 2004; 101: 11404-11409.
13. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002; 125: 2591-2625.
14. Hiraga A, Kuwabara S, Ogawara K et al. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome. Neurology 2005; 64: 856-860.
15. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993; 43: 1911-1917.
16. Ang CW, Laman JD, Willison HJ et al. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. Infect Immun 2002; 70: 1202-1208.
17. van Belkum A, van den Braak N, Godschalk P et al. A Campylobacter jejuni gene associated with immune-mediated neuropathy. Nat Med 2001; 7: 752-753.
18. Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol 2007; 7: 255-266.
19. Jones C, Virji M, Crocker PR. Recognition of sialylated meningococcal lipopolysaccharide by Siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol Microbiol 2003; 49: 1213-1225.
20. Rempel H, Calosing C, Sun B, Pulliam L. Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. PLoS ONE 2008; 3: e1967.
21. Vanderheijden N, Delputte PL, Favoreel HW et al. Involvement of sialoadhesin in entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages. J Virol 2003; 77: 8207-8215.
22. Heikema AP, Bergman MP, Richards H et al. Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharides. Infect Immun 2010; 78: 3237-3246.
23. Avril T, Wagner ER, Willison HJ, Crocker PR. Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides. Infect Immun 2006; 74: 4133-4141.
24. Godschalk PC, Heikema AP, Gilbert M et al. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome. J Clin Invest 2004; 114: 1659-1665.
25. Louwen R, Heikema A, van Belkum A et al. The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion. Infect Immun 2008; 76: 4431-4438.
26. Kuijf ML, Godschalk PC, Gilbert M et al. Origin of ganglioside complex antibodies in Guillain-Barré syndrome. J Neuroimmunol 2007; 188: 69-73.
27. Ang CW, van Doorn PA, Endtz HP et al. A case of Guillain-Barré syndrome following a family outbreak of Campylobacter jejuni enteritis. J Neuroimmunol 2000; 111: 229-233.
28. Kuijf ML, van Doorn PA, Tio-Gillen AP et al. Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA. J Neurol Sci 2005; 239: 37-44.
29. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27: S21-S24.
30. Miller Fisher C. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956; 225: 57-65.
31. Vinson M, van der Merwe PA, Kelm S, May A, Jones EY, Crocker PR. Characterization of the sialic acid-binding site in sialoadhesin by site-directed mutagenesis. J Biol Chem 1996; 271: 9267-9272.
32. Rapoport E, Mikhalyov I, Zhang J, Crocker P, Bovin N. Ganglioside binding pattern of CD33-related Siglecs. Bioorg Med Chem Lett 2003; 13: 675-678.
33. Yuki N. Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain-Barré syndrome. J Neurochem 2007; 103 (suppl 1): 150-158.
34. Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes. Lancet Infect Dis 2001; 1: 29-37.
35. Rinaldi S, Brennan KM, Goodyear CS et al. Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays. Glycobiology 2009; 19: 789-796.
36. Walter RB, Raden BW, Zeng R, Hausermann P, Bernstein ID, Cooper JA. ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, SHP1 and SHP2. J Leukoc Biol 2008; 83: 200-211.
37. Paulson JC, Macauley MS, Kawasaki N. Siglecs as sensors of self in innate and adaptive immune responses. Ann N Y Acad Sci 2012; 1253: 37-48.
38. Bax M, Kuijf ML, Heikema AP et al. Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner. Infect Immun 2011; 79: 2681-2689.